These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38040056)

  • 1. Vitreoretinal Lymphoma with Intraretinal Infiltration, Simulating Retinal Necrosis.
    Guan WX; Peng XY
    Ophthalmol Retina; 2024 Jun; 8(6):571-578. PubMed ID: 38040056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab.
    Cicinelli MV; Marchese A; Miserocchi E; Giuffré C; Berchicci L; Querques G; Bandello F; Modorati GM
    Ocul Immunol Inflamm; 2020 May; 28(4):637-646. PubMed ID: 31393199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
    Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
    Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
    Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
    Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.
    El Zein L; Smith WM; White LJ; Hodge DO; Olsen TW; Pulido JS; Dalvin LA
    BMC Ophthalmol; 2024 Jun; 24(1):255. PubMed ID: 38872120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Silent Masquerade: Clinical and Imaging Features of Asymptomatic Vitreoretinal Lymphoma.
    Menean M; Cicinelli MV; Rivolta MC; Marchese A; Modorati G; Bandello F; Miserocchi E
    Am J Ophthalmol; 2024 Nov; 267():153-159. PubMed ID: 38977150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate.
    Jiang T; Gu J; Liu S; Chang Q
    BMC Ophthalmol; 2022 Sep; 22(1):375. PubMed ID: 36127675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ULTRA-WIDEFIELD MULTIMODAL IMAGING OF PRIMARY VITREORETINAL LYMPHOMA.
    Lavine JA; Singh AD; Sharma S; Baynes K; Lowder CY; Srivastava SK
    Retina; 2019 Oct; 39(10):1861-1871. PubMed ID: 30044267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.
    Barry RJ; Tasiopoulou A; Murray PI; Patel PJ; Sagoo MS; Denniston AK; Keane PA
    Br J Ophthalmol; 2018 Oct; 102(10):1362-1366. PubMed ID: 29306864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal Imaging of Vitreoretinal Lymphoma.
    Mapelli C; Invernizzi A; Barteselli G; Pellegrini M; Tabacchi E; Staurenghi G; Viola F
    Ophthalmologica; 2016; 236(3):166-174. PubMed ID: 27627063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.
    Maggio E; Bauci F; Polito A; Arena F; Pertile G
    BMC Ophthalmol; 2024 Apr; 24(1):194. PubMed ID: 38664667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PERIVASCULAR FLOWER-BUD-LIKE LESIONS ON EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH VITREORETINAL LYMPHOMA.
    Chen W; Gu J; Liu S; Zhao Z; Jiang T; Xu G; Chang Q
    Retina; 2022 Nov; 42(11):2169-2175. PubMed ID: 35982514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
    Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
    Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
    Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2421-2429. PubMed ID: 38446203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
    Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
    Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma.
    Pang CE; Shields CL; Jumper JM; Yannuzzi LA
    Am J Ophthalmol; 2014 Dec; 158(6):1253-1261.e2. PubMed ID: 25174893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHORIORETINAL ATROPHY IN VITREORETINAL LYMPHOMA: Risk Factors and Visual Outcomes.
    Marchese A; Cicinelli MV; Cavalleri M; Bandello F; Modorati G; Miserocchi E
    Retina; 2022 Mar; 42(3):561-568. PubMed ID: 35188494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.